Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACC 2016 BEST OF THE REST: Surgery Trials, More CoreValve Data, Leadless Pacemakers, Drug-Filled Stents, And More

This article was originally published in Clinica

Executive Summary

Almost 19,000 people were in Chicago April 2-4 for the 2016 American College of Cardiology's Annual Scientific Sessions, which featured over 2,400 presentations, including 24 late-breaking trials and 10 other clinical research presentations. Edwards’ transcatheter valves grabbed most of the headlines, but here are some of the other highlights from medical device trial results presented at the meeting

Advertisement

Related Content

ACC 2017: SURTAVI Supports Intermediate-Risk Intervention For Medtronic's CoreValve
US FDA Approves First Intermediate-Risk Indication For TAVR

Topics

Advertisement
UsernamePublicRestriction

Register

MT103331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel